Wellmune WGP is a homoglucose polysaccharide purified from Saccharomyces cerevisiae (Baker’s yeast) that has been recognized since the 1960s to function as an immunomodulator with clinically useful antitumor, hematopoietic and anti-infective properties.

Particulate and soluble preparations of the company’s proprietary beta glucans are highly purified from yeast cell walls in a series of processes that include the removal of lipids, proteins and cell membrane.

Wellmune WGP binds to specific receptors present on human innate immune cells, neutrophils and tissue macrophages, causing enhancement of tumoricidal and microbial killing activity (measured by a number of parameters including phagocytosis, oxidative burst, and tumor killing activity) of these cell types as well as stimulating the proliferation of bone marrow stem cells.